Montag A & Associates Inc Tandem Diabetes Care Inc Transaction History

Montag A & Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$53.22 - $123.09 $1,862 - $4,308	-35 Reduced 63.64%	20 $1,000
Q4 2021 Feb 09, 2022	SELL	$118.18 - $153.21 $2,954 - $3,830	-25 Reduced 31.25%	55 $8,000
Q2 2021 Aug 03, 2021	SELL	$77.0 - $100.19 $8,085 - $10,519	-105 Reduced 56.76%	80 $8,000
Q1 2021 May 14, 2021	SELL	$81.28 - $104.34 $11,379 - $14,607	-140 Reduced 43.08%	185 $16,000
Q4 2020 Feb 12, 2021	BUY	$86.4 - $121.75 $28,080 - $39,568	325 New	325 $31,000

352

73M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.38B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Montag A & Associates Inc with notifications on news.